Diabetic Macular Edema (DME) Unknown Status Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01571232Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaTreatment